Skip to main content
. 2017 Sep 22;8(52):89837–89847. doi: 10.18632/oncotarget.21159

Figure 3. Agarose gel electrophoresis of PF33/pDNA complexes, HAC/pDNA complexes and RRPHC/pDNA nanoparticles.

Figure 3

(A) Lane 1, DNA ladder; lane 2, naked pDNA; lane 3–8, PF33/pDNA at mass ratios of 0.5:1, 1:1, 2:1, 4:1, 8:1, 10:1; lane 9, HAC/pDNA; lane 10, RRPHC/pDNA. (B) Lane 1, DNA ladder; lane 2, naked pDNA; lane 3, PF33/pDNA at mass ratio of 10:1; lane 4, HAC/pDNA; lane 5, RRPHC/pDNA; lane 6, PF33/pDNA after dissociation; lane 7, HAC/pDNA after dissociation; lane 8, RRPHC/pDNA after dissociation.